Novel Oral Anticoagulant versus Warfarin in Cancer Patients with Atrial Fibrillation: An 8-Year Population-Based Cohort Study

Background: Cancer patients with atrial fibrillation (AF) were excluded in the major clinical trials. We therefore investigated the efficacy and safety of novel oral anticoagulant (NOAC) versus warfarin in these patients. Methods: Data were retrieved from Taiwan National Health Insurance Research Da...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cancer
Egile Nagusiak: Wu, Victor Chien-Chia, Wang, Chun-Li, Huang, Yu-Tung, Lan, Wen-Ching, Wu, Michael, Kuo, Chang-Fu, Chen, Shao-Wei, Chu, Pao-Hsien, Wen, Ming-Shien, Kuo, Chi-Ching, Chang, Shang-Hung
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2020
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6930400/
https://ncbi.nlm.nih.gov/pubmed/31892976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.36468
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak